טוען...
Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic
The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risks and benefits of primary PCI vs. th...
שמור ב:
| הוצא לאור ב: | Cardiovasc Revasc Med |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7241397/ https://ncbi.nlm.nih.gov/pubmed/32471712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.carrev.2020.05.027 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|